| |
|
|
|
Aerpio Pharmaceuticals Inc  
|
|
1.15 -0.01 (-0.01%) |
06-05 16:00 |
|
Open: |
1.16 |
Pre close: |
1.16 |
Target:
|
1.79
|
|
High: |
1.18 |
Low: |
1.12 |
Resistance:
|
1.53
1.79
|
|
Volume: |
785,832 |
Market Cap: |
47M |
Support:
|
0.93
0.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.14
 |
MACD |
MACD(12,26):
|
0.13 |
|
MA(20): |
0.88 |
Signal(12,26,9): |
0.10 |
|
MA(100): |
0.67 |
Stochastic Oscillator |
%K(14,3):
|
55.82  |
|
MA(250): |
0.67 |
%D(3): |
55.81 |
|
Average Volume(K) |
3-Month: |
212823
|
52-Week |
High:
|
1.53 |
|
10-Days: |
844754 |
Low: |
0.42 |
|
RSI |
RSI(14):
|
75.17 |
Change(%): |
17.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.463 |
Return on Equity (ttm) |
-44.6 |
Shares Out. (M) |
40.59 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-24.6 |
Shares Float (M) |
26.23 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
24.32 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
27.22 |
|
Forward EPS |
-0.310 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
38 |
|
Book Value (p.s.) |
0.810 |
EBITDA (p.s.) |
-0.438 |
P/E |
-2.48 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.42 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-18.71 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.53 |
P/CF |
-2.49 |
|
|
|
|
|
|
